Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose on Sub-Clinical Inflammation in Early Type 2 Diabetes
NCT00558883Phase 3Completed
- Sponsor
- GWT-TUD
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acarbose in type 2 diabetes mellitus (T2DM), sponsored by GWT-TUD. Started Jan 2005; status: completed.
02
Drugs
acarbose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00558883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558883.